PTSD Trial, Recruiting NCT07062042 Sponsor: Kristiania University College Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT07062042
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are Ukrainian refugees currently living in Norway
  • People who arrived in Norway after 24 February 2022
  • People who are at least 18 years old
  • People who have agreed to participate by giving their informed consent
  • People who, based on screening questionnaires, show signs of PTSD symptoms, have experienced a traumatic event, or have conditions that commonly occur alongside PTSD (such as depression or suicidal thoughts) (confirm with trial site)

Who may not be able to join:

  • People who have a diagnosis, history, or screening results linked to psychotic disorders (confirm with trial site)
  • People who have been diagnosed with a neurodevelopmental disorder (such as autism spectrum disorder or ADHD) (confirm with trial site)
  • People who are currently receiving psychological treatment focused on trauma, such as therapy specifically for PTSD
  • People who do not agree to take part in all required elements of the study, such as screening assessments or the treatment itself

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Vanessa Nolasco Ferreira, Associate Professor, PhD, Kristiania University of Applied Sciences

Phone: +4741231069

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Kristiania University College
Registry
ClinicalTrials.gov
Start date
1 March 2025
Est. completion
20 December 2025

Where this trial is recruiting

🇳🇴 Norway

Primary endpoints

PTSD Symptom Severity (ITQ); Dissociation Symptoms (Shut-D); Depression Symptoms (PHQ-9)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov